Application

OMNIPOD

Insulet Corporation

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97555871
Filing Date: 08/19/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97555871
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\975\558\97555871\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT OMNIPOD
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the stylized wording "OMNIPOD", with the "POD" portion of the word superimposed over a solid stylized depiction of an insulin pump device.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 386 x 250
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Insulet Corporation
*MAILING ADDRESS 100 Nagog Park
*CITY Acton
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
01720
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 009 
*IDENTIFICATION Downloadable software in the nature of applications for mobile phone and smart phones providing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 010 
*IDENTIFICATION Medical devices, including, drug delivery devices, namely, implantable drug delivery pumps and ports, sold empty, smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing, wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty, diabetes management devices, in the nature of blood glucose meters and glucometers, infusion pumps, infusion pump controllers and component parts and attachments thereof
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Interactive medical monitoring, reporting and alert services for infusion pump users for monitoring and managing diabetes; providing a web site for medical professionals and patients featuring medical information and data from devices used for medical monitoring purposes that feed information to the website that is processed, exchanged and accessed in real-time by users
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Karen Feisthamel
ATTORNEY DOCKET NUMBER 8182.T0177
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME KDB Firm PLLC
STREET 2601 Weston Parkway, Suite 103
CITY Cary
STATE North Carolina
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 27513
PHONE 781-205-9633
FAX 919-999-2798
EMAIL ADDRESS kfeisthamel@kdbfirm.com
OTHER APPOINTED ATTORNEY Jeffrey Chamberlain, Trevor Bannister
CORRESPONDENCE INFORMATION
NAME Karen Feisthamel
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE kfeisthamel@kdbfirm.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) lelhamawy@kdbfirm.com; tmdocketing@kdbfirm.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE /Karen Feisthamel/
SIGNATORY'S NAME Karen Feisthamel
SIGNATORY'S POSITION Attorney of record
SIGNATORY'S PHONE NUMBER 781-205-9633
DATE SIGNED 08/19/2022
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97555871
Filing Date: 08/19/2022

To the Commissioner for Trademarks:

MARK: OMNIPOD (stylized and/or with design, see mark)
The literal element of the mark consists of OMNIPOD. The mark consists of the stylized wording "OMNIPOD", with the "POD" portion of the word superimposed over a solid stylized depiction of an insulin pump device.
The applicant, Insulet Corporation, a corporation of Delaware, having an address of
      100 Nagog Park
      Acton, Massachusetts 01720
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 009:  Downloadable software in the nature of applications for mobile phone and smart phones providing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded software and computer hardware for use in insulin monitoring and tracking blood glucose levels; downloadable and recorded software and computer hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software and computer hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 010:  Medical devices, including, drug delivery devices, namely, implantable drug delivery pumps and ports, sold empty, smart delivery devices, sold empty, in the nature of implantable drug delivery pumps and ports for communicating with smart devices for data processing, wearable subcutaneous drug delivery devices, sold empty in the nature of injectors, on-body injectors, all sold empty, diabetes management devices, in the nature of blood glucose meters and glucometers, infusion pumps, infusion pump controllers and component parts and attachments thereof
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Interactive medical monitoring, reporting and alert services for infusion pump users for monitoring and managing diabetes; providing a web site for medical professionals and patients featuring medical information and data from devices used for medical monitoring purposes that feed information to the website that is processed, exchanged and accessed in real-time by users
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Karen Feisthamel. Other appointed attorneys are Jeffrey Chamberlain, Trevor Bannister. Karen Feisthamel of KDB Firm PLLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      2601 Weston Parkway, Suite 103
      Cary, North Carolina 27513
      United States
      781-205-9633(phone)
      919-999-2798(fax)
      kfeisthamel@kdbfirm.com
The docket/reference number is 8182.T0177.
Karen Feisthamel submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Karen Feisthamel
       PRIMARY EMAIL FOR CORRESPONDENCE: kfeisthamel@kdbfirm.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): lelhamawy@kdbfirm.com; tmdocketing@kdbfirm.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Karen Feisthamel/   Date: 08/19/2022
Signatory's Name: Karen Feisthamel
Signatory's Position: Attorney of record
Signatory's Phone Number: 781-205-9633
Signature method: Signed directly within the form
Payment Sale Number: 97555871
Payment Accounting Date: 08/19/2022

Serial Number: 97555871
Internet Transmission Date: Fri Aug 19 12:46:19 ET 2022
TEAS Stamp: USPTO/BAS-XX.X.XX.XXX-202208191246194701
59-97555871-820b2f83172b94978aa63f8eec21
6de46353b8822c19535e4a8e2b5892882-CC-461
82482-20220819123559801766

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed